Journal of Oncology Practice 2014-12-01

Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.

Derek Weycker, Xiaoyan Li, John Edelsberg, Rich Barron, Alex Kartashov, Hairong Xu, GaryH Lyman

Index: J. Oncol. Pract. , (2014)

Full Text: HTML

Abstract

Although studies have evaluated the risk and consequences of febrile neutropenia (FN) among patients receiving cancer chemotherapy in US clinical practice, none have focused on a broad group of patients with metastatic disease.